Evidence map›Paper›PMID 40681257›Full record

ArticleJACC. Case reports2025

QT Prolongation and Ventricular Pre-Excitation in Psychiatric Illness: Have We Pre-Excited our Colleagues?

Hannah Irwin, Michael C Downey, Kevin G Buda, Mengistu Simegn, Rehan Karim

Abstract readCase Reports
In one paragraph

Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hannah IrwinDepartment of Internal Medicine, Hennepin Healthcare, Minneapolis, Minnesota, USA. Electronic address: hannah.irwin@hcmed.org.
Michael C DowneyDepartment of Cardiology, Minneapolis Heart Institute, Minneapolis, Minnesota, USA; Division of Cardiology, Hennepin Healthcare, Minneapolis, Minnesota, USA.
Kevin G BudaDepartment of Cardiology, Minneapolis Heart Institute, Minneapolis, Minnesota, USA; Division of Cardiology, Hennepin Healthcare, Minneapolis, Minnesota, USA.
Mengistu SimegnDivision of Cardiology, Hennepin Healthcare, Minneapolis, Minnesota, USA.
Rehan KarimDivision of Cardiology, Hennepin Healthcare, Minneapolis, Minnesota, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

clinical conditionA 27-year-old male patient presented with acute psychosis complicated by a prolonged corrected QT (QTc) interval in the setting of Wolff-Parkinson-White (WPW) pattern. The patient required antipsychotic medications that are high risk for prolonging the QTc interval and putting the patient at risk for torsades de pointes (TdP). KEY QUESTIONS: The key questions were as follows: 1) How does WPW affect the QTc interval? 2) Does the prolongation of the QTc interval seen in pre-excitation confer increased risk for TdP? and 3) How should patients with WPW and psychiatric illnesses be risk stratified when considering pathway ablation? OUTCOME: Early cardiology involvement allowed safe, early antipsychotic medication initiation. A multidisciplinary team approach resulted in a strategy of early catheter ablation because of the risk for pre-excited atrial fibrillation during future electroconvulsive therapy. TAKE-HOME MESSAGE: Despite broad awareness of the relationship between a prolonged QT interval and TdP, QT prolongation does not always reflect primary ventricular abnormalities that predispose to TdP, allowing the safe administration of antipsychotic agents in patients who need them.

Indexed as

electroconvulsive therapypre-excitationQT prolongationWolff-Parkinson-White

Identifiers

PMID40681257
PMCPMC12441412

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.